1-9 of 9
Spero R Cataland, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Alternative and Terminal Complement Pathway Biomarkers At Presentation More Precisely Define The Clinical Diagnosis Of aHUS

Spero R Cataland, M.D., V. Michael Holers, M.D., Shangbin Yang, Ph.D., Haifeng M Wu, M.D.
Journal: Blood
Blood (2013) 122 (21): 3552.
https://doi.org/10.1182/blood.V122.21.3552.3552
Published: 2013
Journal Articles

Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function In Adult Patients (Pts) With Atypical Hemolytic Uremic Syndrome (aHUS)

Fadi Fakhouri, Maryvonne Hourmant, MD, Spero R. Cataland, M.D., Mario Espinosa, A. Osama Gaber, Jan Menne, Enrico Minetti, Francois Provot, Eric Rondeau, Piero Ruggenenti, Laurent Weekers, Masayo Ogawa, MD, FAAP, Camille L. Bedrosian, MD, Christophe Legendre
Journal: Blood
Blood (2013) 122 (21): 2179.
https://doi.org/10.1182/blood.V122.21.2179.2179
Published: 2013
Journal Articles

Diagnostic and Prognostic Values Of ADAMTS13 Activity Measured During Daily Plasma Exchange Therapy In Patients With Acquired TTP

Nan Wu, Shangbin Yang, Ph.D., Spero R Cataland, M.D., Haifeng M Wu, M.D.
Journal: Blood
Blood (2013) 122 (21): 1079.
https://doi.org/10.1182/blood.V122.21.1079.1079
Published: 2013
Journal Articles

Complement Activation in Patients with Acquired Thrombotic Thrombocytopenic Pupura (TTP)

Shangbin Yang, Spero R Cataland, M.D., V. Michael Holers, M.D., Ante S Lundberg, M.D., Haifeng Wu, M.D.
Journal: Blood
Blood (2012) 120 (21): 3323.
https://doi.org/10.1182/blood.V120.21.3323.3323
Published: 2012
Journal Articles

Mortality From Thrombotic Thrombocytopenic Purpura Is Related to Complement Hyperactivation

Trudy C. Wu, Shangbin Yang, Sara Haven, V. Michael Holers, M.D., Ante S. Lundberg, M.D., Haifeng Wu, M.D., Spero R. Cataland, M.D.
Journal: Blood
Blood (2012) 120 (21): 488.
https://doi.org/10.1182/blood.V120.21.488.488
Published: 2012
Journal Articles

Title: Pretreatment ADAMTS13 Activity Predicts Clinical Outcome in Patients with Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Spero R Cataland, M.D., Susan Geyer, PhD, Shangbin Yang, Haifeng Wu, M.D.
Journal: Blood
Blood (2011) 118 (21): 2224.
https://doi.org/10.1182/blood.V118.21.2224.2224
Published: 2011
Journal Articles

Longitudinal Analysis of VWF Multimerization Patterns In a well-defined TTP Cohort

Shangbin Yang, PhD, Sara Haven, Ming Jin, M.D., Susan Geyer, PhD, Spero R Cataland, M.D., Haifeng Wu, M.D.
Journal: Blood
Blood (2010) 116 (21): 4308.
https://doi.org/10.1182/blood.V116.21.4308.4308
Published: 2010
Journal Articles

Low ADAMTS13 Activity in Clinical Remission Predicts the Risk of TTP Relapses.

Haifeng M. Wu, MD, T. Charles Casper, Spero R. Cataland, M.D., Shili Lin, Ph.D., Melanie Kennedy, M.D., Ming Jin, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 4018.
https://doi.org/10.1182/blood.V110.11.4018.4018
Published: 2007
Journal Articles

Improved Clinical Outcome and ADAMTS13 Activity Following Cyclosporine Therapy in Patients with TTP.

Spero R. Cataland, M.D., James N. George, M.D., Eric H. Kraut, M.D., Tran T. Bourgeois, Amy K. Ferketich, Ph.D., Melanie S. Kennedy, M.D., Michael A. Caligiuri, M.D., Haifeng M. Wu, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 851.
https://doi.org/10.1182/blood.V104.11.851.851
Published: 2004